CENTENE CORP CNC

Financials SIC 6324 - Hospital & Medical Service Plans NAICS Finance and Insurance › Insurance Carriers and Related Activities › Insurance Carriers derived NYSE

Our mission is to transform the health of the communities we serve, one person at a time. As the nation's largest managed care company focused on underserved populations, Centene is committed to helping people live healthier lives. Centene offers affordable and high-quality products to more than 1 in 15 individuals across the nation, including Medicaid and Medicare members (including Medicare Prescription Drug Plans) as well as individuals and families served by the Health Insurance Marketplace.

Centene provides access to high-quality healthcare, innovative programs and a wide range of health solutions that help families and individuals get well, stay well and be well. We believe the best way to deliver healthcare is with a personal approach, with local brands and local teams who live in, care about and directly influence the communities they serve – a key differentiator in our ability to provide access to quality care for our members. Our state-based plans are built on community expertise and backed by the depth, breadth, and experience of a leading national company. Our model is structured around partnership. By working hand-in-hand with providers, policymakers, and communities, we connect people to what matters most – not just healthcare, but essentials like food, housing, utilities, and transportation – to drive meaningful health outcomes.

Last close 70.17 2026-10-23
Market cap $34.66B 2026-06-30 share count
52-week range 31.63 - 72.50

Valuation FY2025 figures against the last close

P/S0.2x
P/E—
P/FCF8.0x
EV/EBITDA—
Dividend yield—
Diluted EPS-13.53

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $174.58B$145.50B$140.09B$135.48B$117.98B$103.80B$70.36B$56.44B$45.62B$37.58B
Cost of revenue $2.67B$2.73B$3.56B$7.03B$4.89B$3.30B$2.46B$2.39B$1.85B$1.86B
Gross profit $14.21B$17.07B$17.64B$16.92B$14.49B$100.50B$67.90B$54.05B$43.77B$35.72B
SG&A $12.90B$12.40B$12.56B$11.59B$9.60B$9.38B$6.53B$6.04B$4.45B$3.67B
Total operating expenses $202.40B$159.90B$151.07B$143.23B$124.20B$108.03B$72.86B$58.66B$47.18B$39.34B
Operating income -$7.62B$3.17B$2.93B$1.32B$1.78B$3.08B$1.78B$1.46B$1.20B$1.26B
Interest expense $678.0M$702.0M$725.0M$665.0M$665.0M$728.0M$412.0M$343.0M$255.0M$217.0M
Pre-tax income -$6.73B$4.26B$3.60B$1.96B$1.81B$2.77B$1.78B$1.37B$1.13B$1.16B
Income tax $51.0M$963.0M$899.0M$760.0M$477.0M$979.0M$473.0M$474.0M$326.0M$599.0M
Net income -$6.67B$3.31B$2.70B$1.20B$1.35B$1.81B$1.32B$900.0M$828.0M$562.0M
EPS, basic -13.536.334.972.092.313.173.192.312.401.76
EPS, diluted -13.536.314.952.072.283.123.142.262.341.71
Shares, diluted (wtd. avg.) 493.1M523.7M545.7M582.0M590.5M579.1M420.4M398.5M353.4M328.0M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $17.89B$14.06B$17.19B$12.33B$13.21B$10.96B$12.13B$5.35B$4.09B$3.94B
Short-term investments $2.43B$2.62B$2.46B$2.32B$1.54B$1.58B$863.0M$722.0M$531.0M$505.0M
Total current assets $40.37B$38.00B$40.76B$30.13B$28.50B$23.39B$20.32B$12.00B$8.70B$8.37B
Property, plant and equipment $2.04B$2.07B$2.02B$2.43B$3.39B$2.77B$2.12B$1.71B$1.10B$797.0M
Goodwill $10.84B$17.56B$17.56B$18.81B$19.77B$18.65B$6.86B$7.01B$4.75B$4.71B
Other intangibles $4.53B$5.41B$6.10B$6.91B$7.82B$8.39B$2.06B$2.24B$1.40B$1.54B
Total assets $76.75B$82.44B$84.64B$76.87B$78.38B$68.72B$40.99B$30.90B$21.86B$20.20B
Accounts payable $13.77B$13.17B$16.42B$9.53B$8.49B$7.07B$4.16B$4.05B$4.17B$3.76B
Short-term debt $50.0M$110.0M$119.0M$82.0M$267.0M$97.0M$88.0M$38.0M$4.0M$4.0M
Total current liabilities $36.70B$34.26B$36.72B$28.46B$25.77B$21.59B$12.93B$11.97B$9.33B$8.62B
Long-term debt $17.35B$18.42B$17.71B$17.94B$18.57B$16.68B$13.64B$6.65B$4.70B$4.65B
Total liabilities $56.69B$55.94B$58.69B$52.63B$51.35B$42.76B$28.30B$19.88B$14.98B$14.14B
Retained earnings $8.67B$15.35B$12.04B$9.34B$8.14B$6.79B$4.98B$3.66B$2.75B$1.92B
Total equity $19.95B$26.41B$25.94B$24.18B$26.94B$25.89B$12.66B$11.01B$6.86B$5.91B

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $5.09B$154.0M$8.05B$6.26B$4.21B$5.50B$1.48B$1.23B$1.49B$1.85B
Depreciation and amortisation $590.0M$549.0M$575.0M$614.0M$565.0M$487.0M$342.0M$237.0M$161.0M$101.0M
Stock-based compensation $204.0M$212.0M$216.0M$234.0M$203.0M$281.0M$177.0M$145.0M$135.0M$148.0M
Capital expenditure $767.0M$644.0M$799.0M$1.00B$910.0M$869.0M$730.0M$675.0M$422.0M$306.0M
Investing cash flow $472.0M-$1.05B-$1.19B-$2.92B-$3.30B-$6.96B-$1.53B-$4.58B-$1.25B-$2.47B
Financing cash flow -$1.62B-$2.41B-$1.66B-$4.20B$1.36B$260.0M$6.83B$4.61B-$82.0M$2.72B
Buybacks $475.0M$3.12B$1.63B$3.10B$297.0M$626.0M$75.0M$71.0M$65.0M$63.0M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001071739-26-000049.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -50B 0 50B 100B 150B 200B Revenue, FY2016: 37.6B Gross profit, FY2016: 35.7B Net income, FY2016: 562M Revenue, FY2017: 45.6B Gross profit, FY2017: 43.8B Net income, FY2017: 828M Revenue, FY2018: 56.4B Gross profit, FY2018: 54B Net income, FY2018: 900M Revenue, FY2019: 70.4B Gross profit, FY2019: 67.9B Net income, FY2019: 1.3B Revenue, FY2020: 103.8B Gross profit, FY2020: 100.5B Net income, FY2020: 1.8B Revenue, FY2021: 118B Gross profit, FY2021: 14.5B Net income, FY2021: 1.3B Revenue, FY2022: 135.5B Gross profit, FY2022: 16.9B Net income, FY2022: 1.2B Revenue, FY2023: 140.1B Gross profit, FY2023: 17.6B Net income, FY2023: 2.7B Revenue, FY2024: 145.5B Gross profit, FY2024: 17.1B Net income, FY2024: 3.3B Revenue, FY2025: 174.6B Gross profit, FY2025: 14.2B Net income, FY2025: -6.7B FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $37.58B $45.62B $56.44B $70.36B $103.80B $117.98B $135.48B $140.09B $145.50B $174.58B
Gross profit $35.72B $43.77B $54.05B $67.90B $100.50B $14.49B $16.92B $17.64B $17.07B $14.21B
Net income $562.0M $828.0M $900.0M $1.32B $1.81B $1.35B $1.20B $2.70B $3.31B -$6.67B

Recent filings and events

  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Officer or director change Item 5.02
  • Regulation FD disclosure Item 7.01
  • Officer or director change Item 5.02
  • Regulation FD disclosure Item 7.01
  • Officer or director change Item 5.02
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Results announced Item 2.02
  • Officer or director change Item 5.02

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 6324

TickerCompanyMarket capP/ERevenue growth
UNH UNITEDHEALTH GROUP INC $375.28B 31.6x 11.8%
ELV Elevance Health, Inc. $95.41B 17.5x 12.5%
CI Cigna Group $81.11B 13.8x 11.2%
HUM HUMANA INC $50.67B 42.9x 31.6%
MOH MOLINA HEALTHCARE, INC. $10.92B 23.4x 11.7%
OSCR Oscar Health, Inc. $9.37B — 39.0%
CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE $2.41B — 40.3%
ALHC Alignment Healthcare, Inc. $1.67B — 46.1%